Level Up Your Supply Chain Initiatives

The modern clinical trial landscape is evolving rapidly, with precision medicine leading the way in curing many heretofore untreatable diseases and conditions. As new biologics and cell and gene therapies are investigated and brought to market through clinical trials, innovative manufacturing techniques are required to develop and safely deliver these medicines. However, shipping and storing these treatments is delicate, and wasted IP is costly. Fortunately, new data accountability technologies are available to alleviate participant and site burdens, making it easier for people to participate in trials and simpler for sites to execute trials and collect quality data.

As companies pioneer emerging therapeutic options such as personalized medicine, they rely on these new technologies to collect vast amounts of diverse data and corresponding endpoints spanning trial sites across the globe. Given the complexities of supply chain logistics and clinical trial data management, robust interactive response technology (IRT) providing a detailed drug accountability program is paramount. Drug accountability and management is a mission-critical aspect of any clinical trial, especially for biopharmaceuticals requiring cold chain management and excursion tracking. Pharmaceutical companies and regulators also need assurance that all necessary information is on the record to meet compliance requirements.

Leveling up supply chain initiatives to ensure accountability, sustainability, and optimized IP management is crucial to meeting these challenges. Fortunately, advancements in drug accountability, wearable devices, and emerging technology such as automation and machine learning can increase supply chain efficiency, capturing real-time factors critical to patient safety and protocol adherence.